Real solutions for genetic disease
Cogent Biosciences (cogentbio.com) scores 71 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 26th percentile of 15259 Healthcare brands.
Cogent Biosciences is a biotechnology company headquartered in Waltham, United States, founded in 2014. It develops precision therapies aimed at addressing genetic drivers of disease, focusing on well-understood genetic mutations. The company targets patients with genetically driven diseases who have significant unmet medical needs, as well as the healthcare providers and researchers who treat and study these conditions. Its stated mission is to improve human health through rational, science-based drug development.
| Brand Name | Cogent Biosciences |
|---|---|
| Domain | cogentbio.com |
| Industry | Healthcare |
| Founded | 2014 |
| Headquarters | Waltham, United States |
| Main Competitors | Blueprint Medicines (79/100), Deciphera Pharmaceuticals (73/100), Incyte Corporation (87/100), Mirati Therapeutics (83/100), PharmaEssentia (78/100) |
Moz Domain Authority 37/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "To develop rational precision therapies that address the true underlying genetic drivers of disease and improve human health." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: Microdata (Schema.org), canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), LinkedIn, Instagram; no detected presence on Facebook, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Cogent Biosciences?", Claude could identify the brand as of October 2026. Cogent Biosciences is a clinical-stage biopharmaceutical company focused on developing precision therapies for genetically defined diseases, most notably its lead drug bezuclastinib, a selective KIT inhibitor being developed for systemic mastocytosis and GIST (gastrointestinal st Best known for Developing bezuclastinib, a selective KIT inhibitor for systemic mastocytosis and GIST.
When asked "Best brands similar to Cogent Biosciences?", Claude would recommend Cogent Biosciences as of October 2026. It's a notable name in precision oncology and mast cell disease treatment, so it would come up in discussions of companies targeting KIT mutations or mastocytosis therapies.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Cogent Biosciences's main competitors in Healthcare: Blueprint Medicines (79/100), Deciphera Pharmaceuticals (73/100), Incyte Corporation (87/100), Mirati Therapeutics (83/100), PharmaEssentia (78/100).
Sources: Brand Analyzer scan
Cogent Biosciences has limited AI-search visibility, scoring 29/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 26, recommendation 48). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Cogent Biosciences official site
Cogent Biosciences was founded in 2014. Cogent Biosciences operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Cogent Biosciences scores 48/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Cogent Biosciences official site
Cogent Biosciences can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Cogent Biosciences official site
Cogent Biosciences is a biotechnology company based in Waltham, United States, founded in 2014. It focuses on developing precision therapies designed to target the genetic drivers underlying specific diseases.
Sources: Cogent Biosciences official site
Cogent Biosciences develops rational precision therapies that target well-understood genetic mutations responsible for disease, aiming to address the true underlying causes rather than just symptoms. The company works from the patient's end need, using validated biology to design targeted treatments.
Sources: Cogent Biosciences official site
Cogent Biosciences scores 29/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Cogent Biosciences has a weak AI-visibility profile at 29/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (48/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 37/100 and thin schema.org structured data. In a live check, Claude could already identify Cogent Biosciences from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Cogent Biosciences: Codoxo (71/100), Codamotion (71/100), Cognoa (71/100), Columbia University Fertility Center (71/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.